Using magnetic stimulation to improve muscle function in spinal muscular atrophy
Official title: Safety and Tolerability of Low Motoneuron Stimulation Via Transcranial Magnetic Stimulation in Spinal Muscular Atrophy
Run by Charitable Foundation Children with Spinal Muscular Atrophy · NCT06977269 · Data updated 2026-11-12
This study is testing whether a type of brain stimulation can help improve muscle function in people with spinal muscular atrophy without them having to do any physical exercise.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Charitable Foundation Children with Spinal Muscular Atrophy Academic / other |
| Locations | 1 site (Kharkiv, Kharkiv Oblast) |
| Status | Recruiting |
| Started | May 19, 2025 |
| Main results expected | December 2025 |
| Study ends | January 2026 |
| Registry record updated | June 18, 2025 |
| Trial ID | NCT06977269 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with 5q-autosomal recessive SMA who can perform minimal hand functions.
✕Probably not a fit
Patients with severe joint contractures or significant cognitive and behavioral issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the safety and tolerability of low motoneuron stimulation using transcranial magnetic stimulation (TMS) in patients with spinal muscular atrophy (SMA). The approach aims to mimic the effects of physical exercise, which can be challenging for SMA patients due to physical and psychological limitations. By applying high-frequency repetitive TMS, the study seeks to engage weak muscle groups and provide therapeutic benefits without requiring active participation from the patients. The study includes specific eligibility criteria to ensure that participants can safely engage with the intervention.
Why it matters
Potential benefit: If successful, this approach could enhance muscle function and overall quality of life for patients with spinal muscular atrophy.
How similar studies have gone: While the use of TMS in this context is innovative, previous studies have shown promise in using similar approaches for neuromuscular conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject has a diagnosis of 5q-autosomal recessive SMA confirmed by DNA test. * Informed consent. * A minimum score of 1 for Entry Item "A" of the Revised Upper Limb Module (RULM) scale for SMA: "Can use hands to hold pencil or pick up a coin/token or drive a powered chair, use phone key pad" Exclusion Criteria: * Subject has severe joint contractures that would affect ability to perform study measures, determined by the study physician. * Subject has a deconditioned respiratory system, per the discretion of the physician investigator. * Subject has behavioral or cognitive problems that preclude participation in the study, in the opinion of the investigator.
Where it's running
-
P.V. Voloshyn Institute of Neurology, Psychiatry and Narcology of the National Academy of Medical Sciences of Ukraine
Kharkiv, Kharkiv Oblast, Ukraine Recruiting
Study contacts
- Principal investigator: Olena V Pisotska, MD, PhD — P.V. Voloshyn Institute of Neurology, Psychiatry and Narcology of the National Academy of Medical Sciences of Ukraine
- Study coordinator: Vitaliy M Matyushenko
- Email: csma.ua@gmail.com
- Phone: 380503640673
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Newborn SMA Screening Service Evaluation
This project tests newborn SMA screening to see if it works well and is acceptable to families in the UK.
-
Biomarker search in SMA using advanced multi-omics
Researchers are trying to see if new biomarkers can help diagnose and monitor spinal muscular atrophy in patients and newborns.
-
Effects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMA
This study tests whether a portable knee-training robot with a compliant vs. rigid stiffness setting improves knee strength in children with spinal muscular atrophy, using each child’s other leg as a comparison.
-
Wearable monitoring of motor development in babies and young children with spinal muscular atrophy detected at birth
This project will try wearing small motion sensors at home to see if they can track how babies and young children diagnosed with spinal muscular atrophy at birth move and develop, compared with healthy children.
-
HABIT-ILE plus Functional Strength Training for Children with SMA
This study will try an intensive HABIT-ILE program combined with functional strength training for children aged 5–17 with SMA who are on stable disease-modifying therapy to see if it improves motor skills.
-
Long-read genetic analysis for Spinal Muscular Atrophy (LOREASI)
This project tries a long-read DNA technique on adults with known SMN1 copy-number patterns to find hidden '2+0' carrier genotypes that standard tests miss.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.